Company Directory / medical devices

Ablative Solutions logo

PrivateFor profitmedical devicesWakefield, United States

Ablative Solutions

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.

Founded
2011
15 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$202M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

201119002026

15 years old.

Reach

Website ranked #6,697,926 in the world for traffic, about 1k visits a month.

What it does

BiotechnologyHealth CareMedical Device

Funding, as listed

$202M currency not stated

  • Rounds8
  • LatestSeries d, Jun 2022
  • Investors5, 4 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersDavid Fischell, Tim Fischell

Every detail we hold

Everything the source datasets list about Ablative Solutions, field by field. Contact details are held but never shown.

The company

Name
Ablative Solutions
Type
For profit
Status
Private
Founded
2011
Founders
David Fischell, Tim Fischell
Industry
medical devices
Categories
Biotechnology, Health Care, Medical Device

Where

City
Wakefield
Country
United States
Markets
Greater Boston Area, East Coast, New England, Northeastern US

Size and reach

Staff band
11-50
Web traffic rank
#6,697,926
Monthly web visits
1,043

Funding, as listed

Total
201,805,500 (currency not stated)
Rounds
8
Latest round
Series d
Latest round date
Jun 2022
Investors
5
Lead investors
4
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Ablative Solutions may be growing as evidenced by the successful clinical trial outcomes of their renal denervation kit, which met its primary endpoint. This achievement is indicative of the company's progress in product development within the medical device sector. Additionally, the results from the TARGET BP I Pivotal Trial, which showed a significant reduction in 24-hour ambulatory blood pressure, suggest that the company's product is effective and could lead to increased adoption in the healthcare market.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

medical devices in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.